C81.7
Other Hodgkin lymphoma
Clinical Classification Guidelines
Inclusion Terms
- Classical Hodgkin lymphoma NOS
- Other classical Hodgkin lymphoma
Medical Intelligence & Overview
Other Hodgkin lymphoma, categorized under ICD-10 code C81.7, refers to a form of Hodgkin lymphoma not classified as classical Hodgkin lymphoma but still part of the broader group of lymphatic system cancers. This category includes various atypical presentations that do not fit the standard criteria for classical types. Although less common, understanding this diagnosis can help patients gain clarity about their condition and the potential treatment paths involved.
Causes & Symptoms
Clinical Causes: Genetic factors that may predispose individuals to lymphoma development Immunodeficiency conditions, such as HIV/AIDS or autoimmune diseases Previous exposure to radiation or certain chemicals Family history of lymphatic or related cancers Possible infections with viruses like Epstein-Barr virus (EBV)
Key Symptoms: Swollen and painless lymph nodes, especially in the neck, armpits, or groin Unexplained weight loss Persistent fatigue and weakness Fever that comes and goes Night sweats Itching skin Shortness of breath or coughing if the lymphoma affects lymph nodes in the chest
Diagnostic & Treatment
Diagnosis Path: Diagnosing other Hodgkin lymphoma involves a combination of clinical examination, imaging tests, and laboratory procedures. Common steps include: - Physical examination to assess lymph node enlargement - Imaging modalities like CT scans or PET scans to evaluate the extent of disease - Lymph node biopsy to analyze tissue under a microscope, essential for definitive diagnosis - Laboratory tests including blood counts and markers - Bone marrow biopsy if spread is suspected Collectively, these steps help determine the precise classification and stage of the disease, guiding treatment options.
Treatment Protocols: Treatment strategies for other Hodgkin lymphoma are tailored based on the individual’s health status and disease stage. Typical approaches include: - Chemotherapy: Often the primary treatment to target cancer cells - Radiation therapy: Used in localized disease to eradicate remaining cancer cells - Targeted therapy: Drugs that address specific molecules involved in cancer growth - Immunotherapy: Boosts the body's natural defenses to fight cancer - Stem cell transplant: Considered for advanced or recurrent cases Patients work closely with healthcare teams to develop personalized plans that aim to achieve remission while minimizing side effects.
Clinical Advice & FAQs
Billing Guidance
Is C81.7 a billable ICD-10 code?
Yes, C81.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.7?
Clinical documentation must specify the nature of Other Hodgkin lymphoma and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
